Come up with a name for your new list and we'll add to it:
Lattice Biologics raised a round of funding on September 16, 2014. Investors include
Grenville Strategic Royalty.
Lattice Biologics specializes in the field of cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration. Lattice develops and processes biologic allograft produ…